Research map: Rational design, expression and refolding of a novel bispecific antibody to simultaneously target VEGF-A and Ang-2 for inhibition of angiogenesis
Back to the article
Papers in this map
PROCHECK: a program to check the stereochemical quality of protein structures
· Roman A. Laskowski · 1993 · 24838 citations · Cited by this paper
Formulation development and evaluation of nasal in situ gel of promethazine hydrochloride- part II: Pharmacokinetic evaluation and bioavailability studies
· 2026 · Related
ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins
· Markus Wiederstein · 2007 · 6080 citations · Cited by this paper
From particle to performance: Linking size-dependent swelling to disintegration mechanisms in natural plant product tablets
· 2026 · Related
Verification of protein structures: Patterns of nonbonded atomic interactions
· Christos Colovos · 1993 · 4579 citations · Cited by this paper
Perfluorocarbon–liquid interface culture method enhances mucus production and allows evaluation of drug permeability through the mucus layer
· 2026 · Related
TM-align: a protein structure alignment algorithm based on the TM-score
· Yang Zhang · 2005 · 4092 citations · Cited by this paper
In-die compressibility as a surrogate for lubrication-induced changes in tabletability
· 2026 · Related
Modes of resistance to anti-angiogenic therapy
· Gabriele Bergers · 2008 · 2967 citations · Cited by this paper
Efficacy of ultraviolet irradiation of pharmaceutical excipients in mitigating N-nitrosamine generation
· 2026 · Related
[20] VERIFY3D: Assessment of protein models with three-dimensional profiles
· David S Eisenberg · 1997 · 2238 citations · Cited by this paper
Elucidation of intermolecular interaction patterns in quaternary solid dispersion complexes of enzalutamide
· 2026 · Related
Bispecific antibodies: a mechanistic review of the pipeline
· Aran F. Labrijn · 2019 · 1332 citations · Cited by this paper
Niclosamide ethanolamine induces malignant phyllodes tumor cell death via mTOR-TFEB axis-mediated lysosomal biogenesis and functional uncoupling
· 2026 · Related
The making of bispecific antibodies
· Ulrich Brinkmann · 2017 · 937 citations · Cited by this paper
Correlation between protein-polydimethylsiloxane visible particle formation and computationally derived antibody surface properties
· 2026 · Related
Protein–Sol: a web tool for predicting protein solubility from sequence
· Max Hebditch · 2017 · 899 citations · Cited by this paper
Identification of a diastereomer of penicilloic acid during acid-mediated degradation of 6-aminopenicillanic acid
· 2026 · Related
Alternative molecular formats and therapeutic applications for bispecific antibodies
· Christoph Spiess · 2015 · 611 citations · Cited by this paper
Mechanistic advances in nanomedicine, nucleic acid therapies, and AI-driven research on cervical cancer
· 2026 · Related
The CamSol Method of Rational Design of Protein Mutants with Enhanced Solubility
· Pietro Sormanni · 2014 · 544 citations · Cited by this paper
Mechanisms of Protein Stabilization and Prevention of Protein Aggregation by Glycerol
· Vincent Vagenende · 2009 · 534 citations · Cited by this paper
Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
· Raluca Ioana Teleanu · 2019 · 516 citations · Cited by this paper
Role of Arginine in Protein Refolding, Solubilization, and Purification
· Kanta Tsumoto · 2004 · 483 citations · Cited by this paper
A Simple Method for Improving Protein Solubility and Long-Term Stability
· Alexander P. Golovanov · 2004 · 482 citations · Cited by this paper
A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme
· Michel E. GOLDBERG · 1991 · 392 citations · Cited by this paper
Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases
· Jörg T. Regula · 2016 · 377 citations · Cited by this paper
The N‐end rule pathway of protein degradation
· Alexander J. Varshavsky · 1997 · 369 citations · Cited by this paper
Targeting angiogenesis in oncology, ophthalmology and beyond
· Yihai Cao · 2023 · 337 citations · Cited by this paper
Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema
· Jayashree Sahni · 2019 · 291 citations · Cited by this paper
Refolding Techniques for Recovering Biologically Active Recombinant Proteins from Inclusion Bodies
· Hiroshi Yamaguchi · 2014 · 288 citations · Cited by this paper
Cation–π interactions in protein–ligand binding: theory and data-mining reveal different roles for lysine and arginine
· Kiran Kumar. V · 2018 · 281 citations · Cited by this paper
AGGRESCAN3D (A3D): server for prediction of aggregation properties of protein structures
· Rafael Zambrano · 2015 · 262 citations · Cited by this paper
[15] Inhibition of aggregation side reactions during in vitro protein folding
· Eliana De Bernardez Clark · 1999 · 256 citations · Cited by this paper
Chapter 17 Refolding Solubilized Inclusion Body Proteins
· Richard R. Burgess · 2009 · 253 citations · Cited by this paper
Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy
· Yvonne Kienast · 2013 · 204 citations · Cited by this paper
Strain engineering for improved expression of recombinant proteins in bacteria
· Tomohiro Makino · 2011 · 203 citations · Cited by this paper
Aggrescan3D (A3D) 2.0: prediction and engineering of protein solubility
· Aleksander Kuriata · 2019 · 200 citations · Cited by this paper
Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy
· Valentin Goede · 2010 · 188 citations · Cited by this paper
Source: OpenAlex (CC0)